InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Browse the full record of transactions filed by MCNAMARA KEVIN J, Chief Executive Officer. Director active across 1 companies, notably CHEMED CORP. In total, 14 filings have been recorded. Total volume traded: €9.8m. The latest transaction was filed on 10 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
€953,1982,000 shares@ €476.59880.016% mcap3.7% of flow
capital stock
SEC:0001209191-22-028215:0·
€1m3,000 shares@ €463.20990.024% mcap5.4% of flow
capital stock
SEC:0001209191-22-026964:0·
€3m10,000 shares@ €282.27440.048% mcap10.9% of flow
capital stock
SEC:0001209191-22-017498:0·
€2m4,977 shares@ €404.49640.034% mcap7.8% of flow
capital stock
SEC:0001209191-22-012049:0·
€1m3,000 shares@ €437.47190.022% mcap14.7% of flow
capital stock
SEC:0001209191-21-064629·
€1m3,000 shares@ €437.47190.022% mcap5.1% of flow
capital stock
SEC:0001209191-21-064629:0·
€5m26,000 shares@ €199.92960.089% mcap58.2% of flow
capital stock
SEC:0001209191-21-062606·
€5m26,000 shares@ €199.92960.089% mcap20.1% of flow
capital stock
SEC:0001209191-21-062606:0·
€1m3,000 shares@ €398.50180.020% mcap13.4% of flow
capital stock
SEC:0001209191-21-050524·
€1m3,000 shares@ €398.50180.020% mcap4.6% of flow
capital stock
SEC:0001209191-21-050524:0·
€1m3,000 shares@ €410.12920.021% mcap13.8% of flow
capital stock
SEC:0001209191-21-038574·
€1m3,000 shares@ €410.12920.021% mcap4.8% of flow
capital stock
SEC:0001209191-21-038574:0·
4,000 shares
capital stock
SEC:0001209191-21-030565·
€772,5204,000 shares@ €193.130.013% mcap3.0% of flow
capital stock
SEC:0001209191-21-030565:0·
14 of 14 declarations
About MCNAMARA KEVIN J
Kevin J. McNamara is the President and CEO of Chemed Corp. He oversees the company's operations and is responsible for implementing growth strategies. With a strong background in the healthcare sector, he leads efforts to enhance services and customer experience. His leadership is essential in positioning Chemed as a key player in the healthcare field.
